Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
about
Yoga for Adults with Type 2 Diabetes: A Systematic Review of Controlled TrialsDiabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetesEffect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressureQuantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sampleA new mouse model of metabolic syndrome and associated complications.Elevated serum neutrophil elastase is related to prehypertension and airflow limitation in obese women.Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity.Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndromeSystemic inflammation and the metabolic syndrome among middle-aged community volunteers.Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review.Metabolic alterations and increased liver mTOR expression precede the development of autoimmune disease in a murine model of lupus erythematosus.Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.Healthcare costs associated with change in body mass index in patients with type 2 diabetes mellitus in Spain: the ECOBIM study.Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients.Evidence in obese children: contribution of hyperlipidemia, obesity-inflammation, and insulin sensitivity.Endothelial barrier dysfunction in diabetic conduit arteries: a novel method to quantify filtration.The effect of pioglitazone on circulating interleukin-10 and tumor necrosis factor-alpha levels in a patient with metabolic syndrome: A randomized, double-blind controlled trialA moderate diet restriction during pregnancy alters the levels of endocannabinoids and endocannabinoid-related lipids in the hypothalamus, hippocampus and olfactory bulb of rat offspring in a sex-specific manner.ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity.Blockade of alpha4 integrin signaling ameliorates the metabolic consequences of high-fat diet-induced obesity.Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetesInflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndromeHepatic function and the cardiometabolic syndrome.Gestational diabetes and pre-eclampsia: common antecedents?Depressive symptoms and increased visceral fat in middle-aged women.Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring.Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease.Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease.Factors associated with metabolic syndrome and related medical costs by the scale of enterprise in KoreaCardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease.Nut consumption for vascular health and cognitive function.Inflammation in Heart Failure: known knowns and unknown unknowns.iNOS inhibition improves autonomic dysfunction and oxidative status in hypertensive obese rats.The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis.Decreased endothelial nitric oxide, systemic oxidative stress, and increased sympathetic modulation contribute to hypertension in obese rats.Inhibitory effects of tannic acid in the early stage of 3T3-L1 preadipocytes differentiation by down-regulating PPARγ expression.[Hormonal and inflammatory impact of different dietetic composition: emphasis on dietary patterns and specific dietary factors].Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox.Personality Correlates of Midlife Cardiometabolic Risk: The Explanatory Role of Higher-Order Factors of the Five-Factor Model.
P2860
Q26770719-0D7CE82B-0C8A-42B7-BC49-04312A4C1B12Q28082521-C3518C00-70AF-4754-BD8C-2D7FF77763D3Q33639013-ECC68A3F-8B48-4231-A976-499255E132E6Q33741200-A830C1CE-6230-48A0-8A0C-F4BD24F85725Q33785757-382BFBAD-4EA0-4DA2-83BB-1A667748E974Q33797345-B8302982-73F3-4014-9528-AC1BAF47B456Q34158063-3B51E129-7E2B-427D-B985-793F143D4458Q34185567-2D08A736-2DF6-4E54-94A2-C35D8F1B644DQ34200504-CABF2D5D-71A4-47F0-A042-B8AB850666F3Q34259995-8DB3E1D4-4392-43A4-80F1-99F5DC411FCAQ34506731-99147882-DED5-4BA1-9C39-8C4B0CC3274CQ34591369-A80CE8B7-6528-480B-A85B-523E72CEAD25Q34728128-4148E0BB-1745-430F-ACBD-433574E75D42Q35342114-D2E67D94-38F8-44C9-993F-A7C23544D6E9Q35642067-AD522341-C46D-4BFC-9C22-D97B2AB2B1D5Q35696044-EEC5DD51-D49B-42D3-B2AE-0FF2313C640DQ35698578-B192735E-986A-4ED8-89D9-6C9738661D5BQ36323986-9E3DC4D4-E96D-4EA2-9F86-CA810F49B74DQ36683234-CB0EE69E-5125-4ED5-BB5D-F181DA541267Q36756506-A9FA4FC1-76D6-48EA-8F32-9AE258373A8DQ37022686-13929227-3127-41CF-8B74-A8DDD02EC4B9Q37090971-45665D3E-816E-494B-8CF9-8358962B8661Q37218337-6A7391E1-95B7-4E23-9E67-20674B7480A5Q37232122-9DCC5321-ECC2-443A-9316-45B365D7B93BQ37280695-A36C9361-722F-42F6-8497-6FDADA314585Q37335800-4D499BD0-E14B-4DA4-B5A3-843E5665EB5FQ37382374-95F7F835-5012-4021-8ACE-6CFA83CCA76DQ37382631-EAA5FA4B-56C7-4A37-99DF-37B91AD6E360Q37484780-FB8B2C4D-0656-403A-A75B-263370DBF3CFQ37581841-97DE3D08-A2E7-4A04-BFD4-A8080165D84AQ37980497-D0BEBE72-B3B8-4DCC-A21D-3FE498BDA16AQ38215357-C7675D9B-22CE-4365-9C76-E32A3001F115Q38692564-1329544A-0E8B-4C71-A20E-3B7D9B6BBC0AQ39038552-15A0406F-C7E9-4A6C-8BB4-D682529649F8Q40164782-D6A08435-957B-470B-ACF9-A9632EAA38B6Q42455825-680BF590-3BE7-4677-BF31-3280382058A6Q42831040-C950020A-ECAC-4000-8263-BF949E649EC3Q43273805-6D05EDA8-1D68-4AA7-A56B-0B7FA5AB9722Q43613518-612ED591-A1EE-4C90-B3C2-F90D907934A0Q44459800-0F2E10B2-C32F-4A2D-AE5A-F7F02E762F16
P2860
Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cardiovascular metabolic syndr ...... es and coronary heart disease.
@ast
Cardiovascular metabolic syndr ...... es and coronary heart disease.
@en
type
label
Cardiovascular metabolic syndr ...... es and coronary heart disease.
@ast
Cardiovascular metabolic syndr ...... es and coronary heart disease.
@en
prefLabel
Cardiovascular metabolic syndr ...... es and coronary heart disease.
@ast
Cardiovascular metabolic syndr ...... es and coronary heart disease.
@en
P2093
P2860
P921
P1476
Cardiovascular metabolic syndr ...... es and coronary heart disease.
@en
P2093
Kastelein JJ
Nieuwdorp M
P2860
P304
P356
10.1111/J.1463-1326.2006.00594.X
P577
2007-05-01T00:00:00Z